Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Tikun Olam-Cannbit Pharmaceuticals Ltd
  6. Summary
    TKUN   IL0010843675

TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD

(TKUN)
 SummaryChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Tel Aviv Stock Exchange
01/16/2022 01/17/2022 01/18/2022 01/19/2022 01/20/2022 Date
3.987 4.054 4.709 5.1 4.941 Last
181293 154574 866848 728380 473132 Volume
-3.88% +1.68% +16.16% +8.30% -3.12% Change
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -10,9 M -3,47 M -3,47 M
Net Debt 2019 14,6 M 4,66 M 4,66 M
P/E ratio 2019 -15,5x
Yield 2019 -
Sales 2020 21,7  6,91  6,91 
Net income 2020 -32,9 M -10,5 M -10,5 M
Net Debt 2020 5,33 M 1,70 M 1,70 M
P/E ratio 2020 -5,03x
Yield 2020 -
Capitalization 200 M 63,9 M 63,8 M
EV / Sales 2019 -
EV / Sales 2020 8 863 230x
Nbr of Employees 100
Free-Float 72,9%
More Financials
Company
Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products. 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD
2021Teva Israel and Tikun Olam-Cannbit Pharmaceuticals Ltd Signs Mutual Collaboration Agree..
CI
2021Tikun Olam-Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Half Year Ended..
CI
2021Tikun Olam-Cannbit Pharmaceuticals Ltd announced that it expects to receive ILS 12 mill..
CI
2021Tikun Olam-Cannbit Continues to Expand Its Footprint in the Pharmaceutical Arena
CI
2021Tikun Olam - Cannbit Pharmaceuticals Ltd Reports Earnings Results for the Full Year End..
CI
2021Canonic of Evogene Group and Tikun Olam-Cannbit, Sign Production and Distribution Agree..
CI
2021Tikun Olam-Cannabit and Opiostop LLC Are Establishing A JV to Conduct A Clinical Study ..
CI
2021Tikun Olam-Cannbit Develops Revolutionary System for the Characterization of Genetic Fi..
CI
2020Cannbit Pharmaceuticals Ltd announced that it expects to receive ILS 11.528 million in ..
CI
2019Cannbit Pharmaceuticals Ltd announced that it expects to receive ILS 10.0344 million in..
CI
2019Cannbit Pharmaceuticals Ltd competed the acquisition of Israel activities from Tikun Ol..
CI
2019Cannbit Pharmaceuticals Ltd signed memorandum of understanding to acquire Israel activi..
CI
2019CANNABIT HOLDINGS LTD. CANCELLED THE : CPHO-M) in a reverse merger transaction.
CI
2019A.L. Capital Holdings Ltd. Auditor Raises 'Going Concern' Doubt
CI
2018CANNABIT HOLDINGS LTD. SIGNED A MEMO : CPHO-M) in a reverse merger transaction.
CI
More news
News in other languages on TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD
2021Teva Israël et Tikun Olam-Cannbit Pharmaceuticals Ltd signent un accord de collaboratio..
More news
Chart TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD
Duration : Period :
Tikun Olam-Cannbit Pharmaceuticals Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Ifat Kariv Chief Executive Officer & Director
Eitan Ben-Eliahu Chairman
Ronen Harel Independent External Director
Revital Aviram External Director
Orit Noked Independent Director